This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Shaanxi University of Science and Technology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ying Zhou: Innovator in Medicinal Chemistry
Introduction
Ying Zhou is a prominent inventor based in Xi'an, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective solutions for combating pathogenic microorganisms.
Latest Patents
Ying Zhou holds a patent for a pleuromutilin derivative containing a thiazole-pyridine benzyl quaternary ammonium salt side chain. This invention includes a preparation method and its use, which is crucial in the development of new antibacterial and anti-mycoplasma drugs. The synthesis method he developed utilizes easily available raw materials and is characterized by simple operation and high product yield, making it suitable for industrial production. The results from in vitro pharmacological experiments indicate that this pleuromutilin derivative exhibits excellent antibacterial properties and solubility, highlighting its potential value in pharmaceutical applications.
Career Highlights
Ying Zhou is affiliated with the Shaanxi University of Science and Technology, where he continues to advance his research in medicinal chemistry. His dedication to innovation has led to the successful development of compounds that can significantly impact the medical field.
Collaborations
Ying Zhou has collaborated with notable colleagues, including Changhua Ke and Kairui Kang, to further enhance his research efforts and contribute to the scientific community.
Conclusion
Ying Zhou's work exemplifies the importance of innovation in medicinal chemistry. His contributions, particularly through his patented pleuromutilin derivative, demonstrate his commitment to developing effective pharmaceutical solutions. His research holds promise for future advancements in combating infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile